MIST – milestone pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
2/3
08:00 am
mist
Low
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/28
07:29 am
mist
Medium
Milestone Pharmaceuticals (NASDAQ:MIST) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/27
08:33 am
mist
Low
Milestone Pharmaceuticals announces U.S. availability of cardamyst [Yahoo! Finance]
1/26
08:18 am
mist
Medium
Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) [Yahoo! Finance]
1/26
08:00 am
mist
Low
Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
11/12/2025
07:01 am
mist
0.0%
BEAT
8/12/2025
07:05 am
mist
0.7%
MISS
5/14/2025
07:04 am
mist
-0.8%
MISS
1/6
12:50 pm
Reiterates
Buy
Buy
HC Wainwright
Low
-0.4%
12/16
10:01 am
Maintains
Overweight
Overweight
Wells Fargo
Medium
-8.1%
12/16
10:01 am
Maintains
Overweight
Overweight
Wells Fargo
Medium
-8.1%
12/16
07:19 am
Reiterates
Overweight
Overweight
Wells Fargo & Company
Medium
-4.8%
12/15
11:00 am
Reiterates
Buy
Buy
HC Wainwright
Medium
-9.3%
2/5
04:31 pm
mist
Low
Form 4/A Milestone Pharmaceutical For: Feb 02 Filed by: Bharucha David
2/5
04:30 pm
mist
Low
Form 4/A Milestone Pharmaceutical For: Feb 02 Filed by: Hasija Amit
2/5
04:30 pm
mist
Low
Form 4/A Milestone Pharmaceutical For: Feb 02 Filed by: Muller Lorenz
2/5
04:30 pm
mist
Low
Form 4/A Milestone Pharmaceutical For: Feb 02 Filed by: Oliveto Joseph
2/5
04:30 pm
mist
Low
Form 4/A Milestone Pharmaceutical For: Feb 02 Filed by: Nelson Jeffrey Edward
Show more
Top News Gainers
4/3 Form SC 13G/A Milestone Pharmaceutical Filed by: Venrock Healthcare Capital Partners II, L.P. 19.2%
5/9 Form 4 Milestone Pharmaceutical For: May 09 Filed by: RTW INVESTMENTS, LP 17.1%
3/6 Q4/2019 12/31/2019 EPS -0.750 ZacksConsensus -0.520 ActVsEst (0.230) - Miss 11.6%
1/2 Form 4 Milestone Pharmaceutical For: Dec 30 Filed by: WONG RODERICK 10.4%
3/24 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. 8.3%
5/24 Form 8-K Milestone Pharmaceutical For: May 24 7.8%
7/8 Milestone Pharmaceuticals: Interesting, But Not Well-Differentiated From Generic Competition [Seeking Alpha] 7.8%
2/5 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) had its "buy" rating re-affirmed by analysts at Piper Sandler. They now have a $26.50 price target on the stock. 5.9%
5/21 Milestone Pharmaceuticals Presents Studies on the Economic Impacts of PSVT at the ISPOR 2019 Annual Meeting 5.7%
1/13 Form 4 Milestone Pharmaceutical For: Jan 13 Filed by: RTW INVESTMENTS, LP 5.6%
Top News Decliners
3/23 Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -87.1%
3/12 Form SC 13D/A Milestone Pharmaceutical Filed by: Novo Holdings A/S -8.4%
3/19 Form 4 Milestone Pharmaceutical For: Mar 02 Filed by: RTW INVESTMENTS, LP -7.3%
6/7 Milestone Pharmaceuticals (MIST) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow [Seeking Alpha] -6.1%
11/8 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.9%
5/15 Form 8-K Milestone Pharmaceutical For: May 13 -3.9%
3/6 Form S-8 Milestone Pharmaceutical -3.8%
6/3 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is now covered by analysts at Cowen Inc. They set a "buy" rating and a $32.00 price target on the stock. -3.3%
11/14 Milestone Pharmaceuticals to Present at Upcoming Investor Conferences -2.9%
10/3 Form 4 Milestone Pharmaceutical For: Oct 01 Filed by: RTW INVESTMENTS, LP -2.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3